Radiology Department, Massachusetts General Hospital, 175 Cambridge Str., Suite 244, Boston, MA, 02114, USA.
U.S. Food and Drug Administration, Silver Spring, MD, USA.
Cardiovasc Intervent Radiol. 2021 Jun;44(6):849-856. doi: 10.1007/s00270-020-02703-2. Epub 2020 Nov 12.
The article is part of the series of articles on radiation protection. You can find further articles in the special section of the CVIR issue. In addition to the risks from fluoroscopic-guided interventional procedures of tissue injuries, recent studies have drawn attention to the risk of stochastic effects. Guidelines exist for preprocedural planning and radiation management during the procedure. The concept of a substantial radiation dose level (SRDL) is helpful for patient follow-up for tissue injury. The uncommon nature of tissue injuries requires the interventionalist to be responsible for follow-up of patients who receive substantial radiation doses. Dose management systems for recognizing and avoiding higher patient exposures have been introduced. The European Directive provides a legal framework and requirements for equipment, training, dose monitoring, recording and optimization that are helpful in radiation risk management.
本文是关于辐射防护的系列文章之一。您可以在 CVIR 问题的特刊中找到更多文章。除了透视引导的介入组织损伤程序的风险外，最近的研究还引起了对随机效应风险的关注。指南可用于术前规划和术中的辐射管理。实质性辐射剂量水平 (SRDL) 的概念有助于对接受大量辐射剂量的患者进行随访。组织损伤的罕见性质要求介入医师对接受大量辐射剂量的患者的随访负责。已经引入了用于识别和避免更高患者暴露的剂量管理系统。欧洲指令为设备、培训、剂量监测、记录和优化提供了一个法律框架和要求，这有助于辐射风险管理。
